Here, journalists can find background information, the latest news, and insights into the work of the Grünhorn Group and the medical cannabis market. Whether you’re looking for an interview with our leading experts, planning a company visit, or have specific press inquiries, we are always available to support your reporting reliably and on time.
Since the introduction of medical cannabis in 2017 and its removal from the German Narcotics Act in April 2024, the Grünhorn Group has established itself as one of the key points of contact for medical professionals and patients in Germany. With our wholesale operations and the country’s largest cannabis pharmacy, we have been a driving force in the industry since 2020. Our network possesses extensive expertise, which we are happy to share with you to advance the public discourse on medical cannabis.
Contact
Communication team
Grünhorn Service GmbH
Permoser Straße 19
04318 Leipzig
presse@gruenhorn.de
Please note that our communications team can only respond to press inquiries. Please address all other requests via the Contact form or by e-mail to support@gruenhorn.de.

Be added to the
press distribution list
LATEST PRESS RELEASES
Klage von Dr. Ansay gegen Grünhorn vor OLG Dresden vollumfänglich abgewiesen
Keine Grundlage für die erhobenen Vorwürfe: bereits dritte unbegründete Klage von Dr. Ansay Leipzig/Dresden, 25.03.2026….
Grünhorn launches integrated platform for cannabis therapy
Partial legalization works: a ray of hope for people in need of therapy
Growth of more than 600 percent: Older people discover cannabis as medicine
Starkes Wachstum bei Patient:innen ab 55 Jahren: Nachfrage nach medizinischem Cannabis steigt seit Teillegalisierung um…


















